Global Processing Services Welcomes Three Independent Non-Executive Directors to Its Board
Global Processing Services (“GPS”), a fast-growing next-gen global payments technology platform, today announced the appointment of Paulette Rowe, Shane Happach, and Lynn McCreary as independent Non-Executive Directors.
Paulette Rowe is one of the most influential women in payments, recognised by American Banker in its annual honours list for three consecutive years, and was formerly CEO of Paysafe’s Integrated and Ecommerce Solutions (IES) division. Paulette brings a wealth of experience across card-based and virtual wallet payment solutions. Prior to Paysafe, Paulette was Head of Payments and Financial Services Partnerships for Facebook and held senior roles in a variety of financial organisations over a 20-year period, including Barclaycard, Royal Bank of Scotland (RBS), Tesco Bank, and GE Capital.
Shane Happach is an experienced global payments executive with strengths in enterprise sales and fintech-led disruption. Shane was recently named as CEO of Singapore-based fintech, Coda Payments. Prior to Coda, Shane was CEO of payments fintech Mollie for two years, and spent more than a decade at Worldpay, where he held a number of senior positions, including EVP, Head of Global Ecommerce and Chief Commercial Officer. Before Worldpay, he worked with GlobalCollect – acquired by Ingenico in 2014 – in business development roles across the Americas and EMEA.
Lynn McCreary brings over three decades of experience in legal, business and executive leadership roles to GPS, having worked at financial services and payments firm Fiserv for 11 years, serving as Chief Legal Officer since 2013. Her responsibilities at Fiserv included directing the firm’s global legal, ethical and compliance activities, as well as taking an active role in coordinating its M&A strategy. Prior to joining Fiserv, Lynn was an equity partner at Bryan Cave LLP, now Bryan Cave Lighton Paisner, where she represented the interests of financial services companies, insurance companies, retailers and others in a broad range of commercial disputes. Lynn is currently Chief Legal Officer of Sportradar.
“Paulette, Shane and Lynn bring a wealth of experience to our Board and will support our team to capitalise on the enormous potential for disruption in the issuer processing space,” said Gene Lockhart, Chair of GPS. “GPS is committed to investing for the long-term to support our clients in accelerating innovation, diversifying product capabilities and facilitating new payments programmes worldwide.”
GPS has attracted a number of highly experienced global payments executives under the leadership of Kevin Schultz as Chief Executive Officer since July 2022. The company most recently announced the appointment of Visa veteran Jim McCarthy as Executive Vice President – Global Product and Sales, who has more than 30 years of payments experience; Kevin Fox as Chief Revenue Officer, and Jeff Burns as Chief Financial Officer.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005772/en/
Contact information
Louisa Bartoszek
Head of Communications, GPS
Louisa.bartoszek@globalprocessing.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 02:00:00 EET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 23:30:00 EET | Press release
Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the cornerstone of Australia’s secure military communications since IS-22’s launch in 2012. SES will build a dedicated ground segmen
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 23:05:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 21:00:00 EET | Press release
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain and stiffness in the global Phase 3 MANEUVER study
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 20:32:00 EET | Press release
Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112241557/en/ Ricimed - Fabentech Ricimed®, an antidote against one of the most toxic natural substances in the world In addition to supportive care, and in severe situations requiring immediate administration, Ricimed® represents a new therapeutic option for the management of acute ricin intoxication. Ricin, among the most dangerous naturally occurring substances, can cause death within hours or days regardless of the route of exposure, making it a major biological threat for many countries. Having demonstrated its ability to specifically target and neutralize ricin before irreversible damage occurs, Ricimed® is an antibody-based therapy relying on poly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom